F11.10 Supports Documentation for Opioid Abuse, Uncomplicated
F11.10 is the ICD-10-CM code for opioid abuse, uncomplicated. In clinical documentation, this code may appear in assessments, treatment plans, progress notes, referral records, and billing-related documentation when the clinician has determined that the client’s presentation supports that diagnosis.
This page is not a guide to assigning diagnoses. Diagnosis selection remains the clinician’s responsibility and should be based on the client’s history, current symptoms, functional impairment, clinical interview, applicable diagnostic criteria, scope of practice, and payer or organizational requirements. AutoNotes does not diagnose clients or choose ICD-10 codes for clinicians.
For therapists, counselors, social workers, psychologists, psychiatrists, and substance use treatment providers, the practical question is usually documentation-related: once F11.10 is clinically appropriate, what information should appear in the note? A useful record generally connects the opioid-related concern to the client’s functioning, treatment goals, interventions, client response, risk considerations, and next steps.
What the F11.10 Code Means in a Behavioral Health Record
The F11 code family relates to opioid-related disorders. The specific code F11.10 indicates opioid abuse without a coded complication such as intoxication, delirium, opioid-induced mood disorder, or remission status. The word “uncomplicated” does not mean the client’s situation is simple. It means the diagnosis code itself does not specify an added opioid-related complication.
Many behavioral health clinicians use clinical language such as opioid use disorder, opioid misuse, relapse risk, cravings, or substance-related impairment in the body of the note. The ICD-10 code label may not match every phrase used in session documentation. That is one reason progress notes should be clinically specific rather than code-dependent.
For example, a note should not simply state, “Client has F11.10.” A stronger note may describe the client’s reported opioid use pattern, cravings, triggers, impact on relationships or work, motivation for change, current supports, and response to interventions used during the session.
Clinical Details That Often Support F11.10 Documentation
Documentation for opioid-related concerns should show the clinical basis for treatment. This does not require long paragraphs in every session note, but the record should give enough context for another qualified provider to understand what was addressed and why.
During an intake, assessment, or updated treatment plan, clinicians may document details such as:
- Type of opioid involved, when clinically relevant, such as prescription opioids, heroin, fentanyl exposure, or non-prescribed use.
- Reported frequency, duration, route, amount, escalation, or periods of abstinence.
- Cravings, urges, withdrawal concerns, relapse triggers, or recent use episodes.
- Functional impact, including family conflict, missed work, legal stressors, financial strain, health concerns, or treatment nonadherence.
The client’s own words can also be useful. A short quote such as “I keep telling myself I can stop, but I use when I’m alone at night” may capture ambivalence, trigger patterns, and readiness for change better than a generic summary.
Clinicians should also document protective factors when present. These may include supportive family members, engagement in therapy, participation in peer support, medication adherence, stable housing, willingness to avoid high-risk contacts, or use of a crisis plan.
Assessment Notes Should Connect Symptoms, Risk, and Level of Care
Assessment documentation for F11.10 often needs more detail than a routine progress note. The assessment may become the reference point for the treatment plan and future clinical updates.
A clear assessment may include the client’s opioid use history, prior treatment episodes, overdose history if disclosed, co-occurring mental health symptoms, trauma history when clinically relevant, medical concerns, prescribed medications, current recovery supports, and barriers to care. The note should also reflect the clinician’s risk assessment and clinical judgment.
Risk documentation should be direct and specific. Instead of writing “risk discussed,” the clinician might document whether the client denied or endorsed suicidal ideation, self-harm, overdose risk, unsafe use patterns, withdrawal concerns, access to naloxone, or need for a higher level of care evaluation. The amount of detail depends on the setting, session type, and presenting concerns.
If the client is receiving services from multiple providers, the record may also describe coordination of care. This could include referrals to a prescriber, primary care provider, opioid treatment program, intensive outpatient program, peer recovery support, or community-based resource. Clinicians should follow consent and privacy requirements before sharing information.
Progress Notes Should Show What Happened in the Session
A progress note for F11.10 should do more than repeat the diagnosis. It should describe the session focus, interventions used, client response, progress toward goals, and the plan for continued care.
Depending on the documentation format used in the practice, the note may follow SOAP, DAP, BIRP, GIRP, or another structured format. The format matters less than the clinical clarity. A payer, supervisor, auditor, or future treating provider should be able to see what service was provided and how it related to the client’s treatment needs.
Example DAP-style progress note language
Data: Client reported increased cravings over the past week after contact with a former using peer. Client denied opioid use since last session and reported attending two recovery meetings. Client described difficulty sleeping and increased irritability. Therapist used motivational interviewing to explore ambivalence about blocking the peer contact and used CBT-based coping planning to identify evening triggers.
Assessment: Client remains engaged in treatment and demonstrates insight into relapse triggers. Cravings appear elevated in response to social exposure and poor sleep. Client was receptive to coping plan and identified two alternative supports to contact during high-risk periods. No suicidal ideation reported during session.
Plan: Client will block high-risk contact, attend at least one recovery meeting before next session, and practice a written craving management plan during evening hours. Therapist will continue relapse prevention work and review sleep-related coping strategies next session.
This example is not a required template. It shows the level of specificity that can make opioid-related documentation more clinically useful.
Treatment Plans Should Translate F11.10 Into Measurable Goals
A treatment plan connected to F11.10 should identify what the client is working toward, how progress will be measured, and what interventions the clinician will provide. Goals should be realistic for the client’s stage of change and level of care.
Common treatment planning areas may include reducing opioid use, maintaining abstinence, increasing coping skills, improving recovery support, addressing co-occurring anxiety or depression, repairing relationships, increasing appointment attendance, or coordinating medication-related care when appropriate.
Examples of measurable goals include:
- Client will identify at least three personal relapse triggers and three coping responses within 30 days.
- Client will attend scheduled therapy sessions weekly for the next eight weeks.
- Client will develop a written safety or relapse prevention plan, including support contacts and emergency steps.
- Client will report use of at least two non-opioid coping strategies during craving episodes.
Interventions may include motivational interviewing, CBT, relapse prevention planning, psychoeducation, skills training, contingency planning, family involvement when appropriate, and coordination with medical or substance use treatment providers. If medications for opioid use disorder are part of the client’s care, documentation should reflect the clinician’s role, such as referral, coordination, adherence support, or monitoring of behavioral goals within scope.
Related ICD-10 Codes Clinicians May See Near F11.10
Clinicians may encounter other opioid-related ICD-10 codes in records, referrals, or prior authorizations. These codes can reflect remission status, intoxication, or opioid-induced conditions. The presence of a related code does not mean it should be selected for a specific client. The clinician must determine the appropriate diagnosis and code based on the client’s presentation and applicable requirements.
- F11.11 — Opioid abuse, in remission.
- F11.120 — Opioid abuse with intoxication, uncomplicated.
- F11.121 — Opioid abuse with intoxication delirium.
- F11.14 — Opioid abuse with opioid-induced mood disorder.
Related codes are one reason documentation should describe current symptoms and status clearly. A client actively working on cravings and relapse prevention may require different documentation than a client in sustained remission, a client presenting with intoxication concerns, or a client whose mood symptoms appear connected to opioid use.
Common Documentation Gaps With F11.10 Notes
Opioid-related notes can become vague when clinicians are rushed. Short notes are not automatically poor notes, but they should still include enough clinical substance to support the service.
Common gaps include writing only “processed substance use,” omitting the client’s response to the intervention, failing to update relapse risk, leaving out progress toward treatment goals, or using the same note language across multiple sessions. Another frequent issue is documenting opioid use history at intake but not connecting later sessions back to the treatment plan.
A stronger progress note may answer five practical questions:
- What opioid-related issue or recovery goal was addressed today?
- What intervention did the clinician provide?
- How did the client respond?
- What changed, improved, worsened, or stayed the same?
- What is the plan before the next session?
These questions help clinicians create notes that are concise, specific, and clinically meaningful without turning every session into a lengthy narrative.
How AutoNotes Helps Clinicians Draft F11.10 Documentation
AutoNotes helps behavioral health professionals create structured, editable progress note drafts from session details. For clinicians documenting opioid-related concerns, that can mean a faster starting point for notes that include interventions, client response, progress toward treatment goals, and next steps.
The clinician remains in control. AutoNotes does not assign F11.10, determine whether a client meets diagnostic criteria, or replace clinical judgment. Instead, it supports the documentation workflow after the clinician provides the relevant session information and reviews the draft.
For opioid abuse documentation, clinicians can use AutoNotes to support:
- Progress notes: Draft SOAP, DAP, or other structured notes that reflect the session focus and intervention.
- Treatment planning: Organize goals, objectives, and interventions related to relapse prevention, coping skills, and recovery support.
- Assessments: Capture clinically relevant history, symptoms, risk factors, strengths, and recommended next steps.
- Consistency: Keep note structure more predictable across clients, services, and session types.
Generic AI writing tools often require clinicians to build the structure themselves. AutoNotes is designed for behavioral health documentation, with templates and workflows shaped around therapy sessions, assessments, treatment plans, and other clinical services.
Build a Cleaner Documentation Workflow for Opioid-Related Care
F11.10 documentation works best when the record clearly connects the diagnosis, treatment focus, intervention, client response, and plan. Clinicians do not need to write long notes for every session, but they do need notes that show the clinical work performed and the reasoning behind ongoing care.
A practical workflow may include reviewing the treatment plan before session, documenting opioid-related changes during or soon after the appointment, noting risk and protective factors, and finalizing the progress note while the session is still fresh. AI-assisted drafting can reduce the blank-page problem, but the final note should always reflect the clinician’s review and clinical judgment.
If documentation is taking over evenings or creating inconsistent notes across your caseload, AutoNotes can help you create structured drafts faster while keeping you in control of the final record. Start your free trial and see how editable, clinician-reviewed note drafts can fit into your documentation process.
